Roche launches a digital PCR system, a powerful new diagnostics platform in the fight against cancer and other diseases

The DigitalLightCycler System is a next-generation digital PCR system that helps clinicalresearchers better understand the nature of a patient ’s cancer, genetic disease or infection.The newsystem has the potential to find and quantify ultra-rare, hard to detect mutations, leading to early diagnosis and treatment strategies.The DigitalLightCycler Systemis designed for laboratories performing highly sensitive and precise DNA and RNA analysis in areas such as oncology and infectious diseases.Basel, 23 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Digital LightCycler Ⓡ System, Roche’s first digital polymerase chain reaction ( PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods.The Digital LightCycler System will allow clinical researchers to divide DNA and RNA from an already extracted clinical sample into as many as 100,000 microscopic individual reactions. The system can then perform PCR and produce highly sophisticated data analysis on the results." Understanding the hidden characteristics of serious diseases is fundamental for ensuring that the most effective treatment is selected for each patient, " said Thomas Schinecker, CEO of Roche Diagnostics. “The Digital LightCycler System will support clinical researchers and laboratories in identifying rare and emerging disease mutations. This can...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news